Drug Topics October 25, 2024
Brian Nowosielski

As the H5 bird flu outbreak gradually impacts human health in the US, health care experts weighed in on possibilities of a future vaccine.

The H5 bird flu outbreak in the US started at the end of March 2024 when a commercial dairy farm worker in Texas reported conjunctivitis and shortly after tested positive for the bird flu.1 Since then, contaminated milk has been found on grocery store shelves, the first human without animal exposure contracted the virus, and 30 additional cases have been reported in the US. And with all of these developments ongoing, risk of a greater public health crisis spurred on by the bird flu is still considered low, according to public health experts.2

However, despite no...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Healthcare System, Interview / Q&A, Pharma / Biotech, Public Health / COVID, Trends
Pharma Pulse 2/24/25: Enhancing Pharma Supply Chain Transparency and Trust, Growing Obesity Crisis is Driving Up Healthcare Costs & more
Manas AI Launches to Transform Discovery of Novel Cancer Medicines
Trump administration, pharma clash: 4 notes
Nvidia Invests Further Into Healthcare And Releases The Largest Biology Foundation Model With The Arc Institute
PepGen Drug Shows Signs of Topping Rivals in Rare Muscle Disease With No Approved Meds

Share This Article